Navigation Links
GBS/CIDP Foundation to Hold 10th International Symposium
Date:10/7/2008

Over 250 medical professionals, patients and caregivers from around the

world expected to attend

NARBERTH, Pa., Oct. 7 /PRNewswire/ -- The GBS/CIDP Foundation International will host its tenth international symposium on Guillain-Barre Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Bloomingdale, IL on November 7-9, 2008. Over 250 medical professionals, current and former patients and caregivers from all over the world are expected to attend the three-day event at the Indian Lake Resort.

In addition to general sessions covering the latest developments in current research, diagnosis, treatment and therapies for GBS & CIDP, there will be over twenty workshops offering practical information for patients, caregivers and their physicians. Topics include patient management and long-term outcomes for GBS, CIDP and variants, fatigue, pain and emotional issues, reimbursement and disability, and special sessions for rehabilitation and wheelchair patients.

Speakers and presenters include prominent neurologists who actively treat GBS and CIDP patients and conduct vital research, leading physicians in rehabilitation medicine and physicians who themselves have had the disorder. The symposium will provide invaluable information and networking opportunities for patients, relatives and caregivers who have experienced or had to deal with these rare and potentially catastrophic disorders.

GBS is an inflammatory disorder of the peripheral nerves and is characterized by the rapid onset of weakness and often paralysis of the legs, arms, breathing muscles and face. GBS can develop in persons of any age. CIDP is a rare disorder of the peripheral nerves with weakness occurring over two or more months and is characterized by gradually increasing weakness of the legs and, to a lesser extent, the arms. It is caused by damage to the covering of the nerves, called myelin.

The Foundation was founded in 1980 by Robert and Estelle Benson to assist GBS patients and their families. A non-profit volunteer organization, it is dedicated to supporting patients and families through its national office and 160 chapters with more than 26,000 members around the globe. In addition to education of the public and medical communities the Foundation is dedicated to funding medical research and supporting patient advocacy.

For information about the Foundation or the Symposium, call toll free 866-224-3301 or visit http://www.gbs-cidp.org, or e-mail info@gbs-cidp.org.

For further information, contact:

Estelle Benson

Executive Director

(610) 667-0131

(866) 224-3301 (toll free)


'/>"/>
SOURCE The GBS/CIDP Foundation International
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. GeneGo and the Cystic Fibrosis Foundation Collaborate to Advance Understanding of Cystic Fibrosis
2. More Than 230 Cyclists to Ride in Amgen California Coast Classic Bike Tour to Raise $1.3 Million for Arthritis Foundation
3. International Atomic Energy Agency and National Foundation for Cancer Research Launch Major Initiative to Improve Cancer Prevention and Treatments in Developing Countries
4. Melanoma Research Foundation and Seattle Cancer Care Alliance Host Educational Symposium and Reception for Melanoma Patients, Family Members and Healthcare Providers
5. Foundation for Biomedical Research Board Chairman Awarded Congressional Gold Medal
6. The Parkinsons Disease Foundation Commemorates its 50th Anniversary with Special Scientific Symposium on Parkinsons Disease
7. Rutgers physicist earns prestigious Packard Foundation Science and Engineering Fellowship
8. Agendia BV Announces That its Chief Research Officer Laura van t Veer has Received a 2007 Breast Cancer Research Foundation Award
9. John Timberlake, Valeritas Executive Vice President and General Manager, Named Executive of the Year by the Diabetes Foundation
10. Genasense(R) Triple Combination Therapy in Advanced Melanoma Presented at Chemotherapy Foundation Symposium
11. eHealth Initiative Foundation Launches Collaborative Research Effort to Improve Drug Safety
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... TOKYO , June 24, 2016  Regular discussions on ... to take place between the two entities said Poloz. ... in Ottawa , he pointed to the ... and the federal government. ... Poloz said, "Both institutions have common economic goals, why not ...
(Date:6/23/2016)... ... 2016 , ... UAS LifeSciences, one of the leading manufacturers ... Probiotics, into Target stores nationwide. The company, which has been manufacturing high quality ... list of well-respected retailers. This list includes such fine stores as Whole Foods, ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is ... has received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval ... Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods ...
(Date:6/23/2016)... ... , ... STACS DNA Inc., the sample tracking software company, today announced that ... joined STACS DNA as a Field Application Specialist. , “I am thrilled that ... of STACS DNA. “In further expanding our capacity as a scientific integrator, Hays brings ...
Breaking Biology Technology:
(Date:5/24/2016)... Ampronix facilitates superior patient care by providing unparalleled technology to leaders of the medical ... premium product recently added to the range of products distributed by Ampronix. ... ... ... Ampronix News ...
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:4/28/2016)... , April 28, 2016 Infosys ... (NYSE: INFY ), and Samsung SDS, a global ... that will provide end customers with a more secure, fast ...      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... but it also plays a fundamental part in enabling and ...
Breaking Biology News(10 mins):